Lung Resistance Protein and Multidrug Resistance Protein in Non-Small Cell Lung Cancer and Their Clinical Significance
Authors:
Open Access
- 1 October 2011
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 39 (5) , 1693-1700
Abstract
This study examined lung resistance protein (LRP) and multidrug resistance protein (MRP) in lung tumour tissue from 92 patients with non-small cell lung cancer (NSCLC) and normal lung tissue from 20 patients with benign lung tumours. The rates for LRP- and MRP-positive tumours among the NSCLC cases were 54% and 59%, respectively, and their combined positive rate was 45%. These rates were significantly higher than in normal lung tissue. The rates of LRP- and MRP-positive tumours were significantly higher among cases of adenocarcinoma than in cases of squamous cell carcinoma, and in highly differentiated tumours compared with tumours of low or moderate differentiation. There was a significant association between LRP- and MRP-positive tumours and a decrease in overall survival. In conclusion, LRP and MRP play a role in multidrug resistance in NSCLC and are related to prognosis in patients with NSCLC.Keywords
This publication has 12 references indexed in Scilit:
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Expression of multidrug resistance–associated proteins in rhabdomyosarcomas before and after chemotherapy: The relationship between lung resistance–related protein (LRP) and differentiationHuman Pathology, 2003
- Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cellsToxicology in Vitro, 2002
- Protein expression profiles indicative for drug resistance of non-small cell lung cancerBritish Journal of Cancer, 2002
- Drug resistance in non-small cell lung cancerLung Cancer, 2001
- Cloning and Initial Analysis of the Human Multidrug Resistance-Related MVP/LRP Gene PromoterBiochemical and Biophysical Research Communications, 2000
- Expression of the major vault protein LRP in human non-small-cell lung cancer cells: Activation by short-term exposure to antineoplastic drugsInternational Journal of Cancer, 2000
- Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapyCancer Letters, 1998
- Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell linesInternational Journal of Cancer, 1997
- Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissuesAnnals of Oncology, 1996